| |
|
About PRIALT: From Marine Inhabitant to Neuropathic Pain Specialist
PRIALT is thought to work differently than other pain drugs. PRIALT is a first in its class of N-type calcium channel blockers that reduces the release of excitatory neurotransmitters from the primary afferent nerve terminals in animals; the mechanism of action has not been established in humans
- A non-opioid analgesic that is a synthetic equivalent of a naturally occurring conopeptide derived from the marine sea snail, Conus magus
- Significant neuropathic pain relief and pain control as defined by:
- Visual Analog Scale of Pain Intensity (VASPI)
- Categorical Pain Relief Scale (CPRS)
- Clinical Global Impression (CGI)
- Proven efficacy in patients with neuropathic pain
- Evaluated in more than 1,200 patients over 662 patient years
- Available in multiple vial strengths and sizes
- Patient medical assistance available through Elan-supported programs
|
|
|
is a trademark of Elan Pharmaceuticals, Inc.